Heather H. Cheng, Sabree Burbage, Carmine Rossi, Ibrahim Khilfeh, Lilian Diaz, Yuxi Wang, Dominic Pilon, Gordon Andrew Brown, Neal D. Shore, Benjamin H Lowentritt, Daniel W. Lin, Mehmet Asim Bilen. "Real world comparison of time-to-next-treatment (TTNT), time-to-castration-resistance (TTCR), and overall survival (OS) among patients with BRCA1/2 positive and homologous recombination repair (HRR) negative metastatic castration-sensitive prostate cancer (mCSPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.77